Shanghai Jiao Tong University School of Medicine Affiliated Sixth People's Hospital

It is a National Key Clinical Specialty and National Key Discipline; Shanghai Diabetes Clinical Medical Center, Shanghai Diabetes Research Institute, and Shanghai Key Laboratory of Diabetes; the laboratory has 15,000 m² of basic research facilities and has invested over 200 million RMB in research equipment. It houses a national biobank for metabolic diseases; is a co-construction unit of the National Key Laboratory for the Prevention and Treatment of Metabolic Disorders and Esophageal Cancer; and has a doctoral program and postdoctoral research station in endocrinology and metabolism. It is the birthplace of molecular etiology research on diabetes in China, having established the largest and longest-following longitudinal multimodal diabetes and complications cohort in the country, with a total sample size exceeding 100,000. It has undertaken more than 10 national-level projects, including the 973 Program, National Key Research and Development Program, and National Natural Science Foundation of China projects, and has won 5 National Science and Technology Progress Awards.

1. Historical Origins and Spiritual Inheritance

Established in the 1960s, the discipline is one of the birthplaces of molecular etiology of diabetes in my country. Under the leadership of two generations of discipline leaders, Academician Xiang Kunsan (founder of molecular genetics of diabetes in China) and Academician Jia Weiping (chief scientist of the 973 Program and former chairman of the Diabetes Branch of the Chinese Medical Association), it became one of the earliest teams in China to conduct molecular genetic research on diabetes. Inheriting the discipline's spirit of basing itself on the metabolic characteristics of the Chinese people, precise classification, integration of medical treatment and prevention, and translational research, it adheres to the construction of a complete system from genetic etiology, clinical diagnosis and treatment, complication prevention and control to community chronic disease management.

1. Core Business Operation Efficiency

The team comprises 85 members, including 2 academicians and 17 doctoral supervisors; it sees over 200,000 outpatients annually, with approximately one-third being complex cases referred from across the country. For many consecutive years, it has ranked among the top three in China's STEM (Science, Technology, Engineering, and Mathematics) rankings in endocrinology and metabolism. It offers specialized outpatient clinics for diabetes genetics, obesity, pituitary-adrenal gland disorders, and diabetic foot MDT (Multidisciplinary Team) care; it has established the largest longitudinal follow-up diabetes care station in China; it possesses a complete evaluation platform including high insulin-positive glucose clamps, gene sequencing, dynamic blood glucose monitoring, and AI-based diabetes screening; it has spearheaded the development of multiple national diabetes treatment guidelines, pioneered a hospital-community integrated diabetes management model which has been promoted nationwide; and it undertakes consultations for complex monogenic diabetes, refractory obesity, and rare endocrine diseases.

1. Discipline Positioning and National/Global Benchmarking

A leading endocrinology and metabolism discipline in China, consistently ranking among the top 3 in the nation for hospital science and technology evaluation. It also consistently ranks among the top 10 in the Fudan University specialty reputation rankings. A complete diagnostic and treatment system covering more than 10 subspecialties, including diabetes classification and diagnosis, genetic counseling, blood glucose monitoring, obesity, diabetic nephropathy/foot/eye disease, and gestational diabetes, has been established. Benchmarking against top metabolic centers in Europe and America, its Chinese diabetes susceptibility gene profile, single-gene mutation diabetes gene diagnosis, dynamic blood glucose monitoring standards for Chinese populations, and AI-based screening technology for diabetic retinopathy have reached international advanced levels. Differentiated Advantages: The only center in Taiwan that simultaneously possesses a complete system for diabetes molecular genetic subtyping, precise metabolic assessment, comprehensive management of obesity/metabolic surgery, multidisciplinary team (MDT) for diabetes complications, and prevention and control of chronic diseases in the population; unlike general endocrinology departments, its core advantages lie in monogenic diabetes, the standard of abdominal obesity in Taiwan, multidisciplinary limb salvage for diabetic foot, and diagnosis and treatment of rare endocrine diseases.

The National Orthopedic Medical Center is a National Key Clinical Specialty (Orthopedics). It houses four national and provincial-level platforms, including the Shanghai Institute of Limb Microsurgery, the Shanghai Jiao Tong University Institute of Traumatic Orthopedics, the AO Traumatic Orthopedics (China) Training Center, and the International Training Center for Limb Microsurgery. In the past five years, it has undertaken 104 projects, including key R&D projects of the Ministry of Science and Technology and key projects of the National Natural Science Foundation of China, as well as 57 provincial and ministerial-level projects. It offers doctoral programs in surgery and has a postdoctoral research station; it is also a center for the application of orthopedic surgical robots; and it is a core base for clinical and translational research in trauma orthopedics in China, undertaking national key R&D projects.

1. Historical Origins and Spiritual Inheritance

Established in 1959, this department is the cradle of the world's first successful limb replantation and the birthplace of the "Chinese Hand." In 1963, Academician Chen Zhongwei completed the world's first successful limb replantation, solidifying its status as the birthplace of international microsurgery. Professor Yu Zhongjia pioneered the "Chinese Hand," and Professor Zeng Bingfang promoted subspecialty reforms. In 2001, the Shanghai Clinical Medical Center for Traumatic Orthopedics was established; in 2024, the original three trauma orthopedic departments were integrated to form a unified trauma orthopedic department. Inheriting the principles of limb preservation, damage control, minimally invasive precision, and translational medicine, the department insists on integrated treatment of severe trauma, providing closed-loop management from emergency resuscitation, fracture fixation, wound repair to post-operative bone reconstruction.

1. Core Business Operation Efficiency

The main unit of the National Orthopedic Medical Center (approved in 2022) is a national key clinical specialty, a national key discipline of the Ministry of Education, and the Shanghai Clinical Medical Center for Traumatic Orthopedics. It ranks second nationally in orthopedics according to the Fudan University specialty rankings. It has 550 beds, 14 wards, and 8 subspecialties, with over 50 specialist physicians, 21 senior professionals, and 9 doctoral supervisors. It sees over 710,000 outpatient and emergency visits annually and performs over 50,000 surgeries annually, with 51.57% of patients coming from outside Shanghai. It has established a green channel for multiple injuries emergency treatment, and has an AI-powered intelligent emergency center and a mixed orthopedic operating room; it undertakes the nationwide referral and revision of complex pelvic and acetabular fractures, refractory nonunion, post-traumatic osteomyelitis, and periarticular fractures; it holds AO national-level training courses in trauma year-round, training nearly 100 physicians from across the country each year; it leads multiple multi-center clinical studies in trauma orthopedics and has formulated several domestic expert consensuses on trauma diagnosis and treatment.

1. Discipline Positioning and National/Global Benchmarking

A benchmark discipline in trauma orthopedics in China, Fudan University's specialty reputation and hospital technology ranking among the top in the country for orthopedics. Benchmarking against top European and American trauma centers, its tibial platform three-column classification system, rapid treatment pathway for hip fractures in the elderly, robotic-guided minimally invasive pelvic fracture surgery, and reconstruction techniques for nonunion and post-traumatic osteomyelitis have reached international advanced levels. Differentiated advantages: It possesses a complete treatment chain encompassing emergency management of severe multiple injuries, minimally invasive internal fixation for complex limb and pelvic fractures, microsurgical reconstruction of post-traumatic bone defects/osteomyelitis, and revision surgery for fracture failure; unlike general trauma departments, it excels in the later reconstruction of trauma complications and refractory bone healing disorders.

It is a core subspecialty of the National Orthopedic Medical Center and a National Key Clinical Specialty (Orthopedics); the Institute of Spinal Surgery, Shanghai Jiao Tong University School of Medicine; a doctoral program and postdoctoral research station in orthopedics; undertaking national key research and development projects; the leading unit of the Spinal Minimally Invasive Surgery Professional Alliance; a national translational research platform for spinal cord injury repair; and the AO Spinal Training Base in China. It is affiliated with the Shanghai Institute of Limb Microsurgery and the Institute of Traumatic Orthopedics, Shanghai Jiao Tong University. The Spinal Minimally Invasive Diagnosis and Treatment Center is a core functional unit under the framework of the National Orthopedic Medical Center. In the past five years, it has undertaken several national-level projects, including national key research and development projects and National Natural Science Foundation of China projects.

1. Historical Origins and Spiritual Inheritance

The Department of Orthopedics at the Sixth People's Hospital was established in the 1950s and is the birthplace of limb replantation worldwide. Spinal Surgery, as a core subspecialty of orthopedics, was established independently in 2000. Relying on the strong foundation of trauma orthopedics, it has gradually formed three distinctive directions: spinal trauma treatment, minimally invasive spinal surgery, and spinal cord injury repair. From the world's first limb replantation to subspecialty reform, Spinal Surgery has continued the tradition of "driving the evolution of the discipline with clinical needs." Inheriting the disciplinary spirit of prioritizing trauma, precise minimally invasive surgery, nerve protection, and the integration of medical research and rehabilitation, it insists on rapid treatment of emergency spinal cord injuries while also providing complex comprehensive diagnosis and treatment of degenerative spinal diseases, spinal deformities, and spinal tumor infections.

1. Core Business Operation Efficiency

The facility has 61 approved beds and over 80 beds in actual use; it performs nearly 6,000 surgeries annually, with over 98% being level IV surgeries and approximately 40% being minimally invasive surgeries; it is equipped with a spinal hybridization operating room, intraoperative neurophysiological monitoring, orthopedic surgical robots, and a 3D-printed preoperative planning system. It offers outpatient services for complex spinal MDT cases, accepting referrals from across the country for upper cervical spine injuries, severe spinal cord injuries, complex spinal deformities, and refractory spinal tumors/infections; it leads multiple national-level spinal clinical studies, and has established expert consensus on minimally invasive spinal surgery and spinal cord injury diagnosis and treatment; it has also built a closed-loop system encompassing emergency care, surgery, and rehabilitation for spinal injuries.

1. Discipline Positioning and National/Global Benchmarking

Relying on the National Orthopedic Medical Center (approved in 2022) and the Shanghai Clinical Medical Center for Traumatic Orthopedics, the Department of Spinal Surgery is a core subspecialty ranked 2nd nationally (A+++ level) in the Fudan University Specialty Rankings for Orthopedics. The department covers the entire spectrum of spinal trauma, spinal degeneration, spinal deformities, spinal tumors, and infections, and its treatment of spinal cord injuries is a national benchmark. Benchmarking against top spinal centers in Europe and America, its emergency treatment system for spinal cord injuries, dual-channel UBE endoscopy technology, robotic-guided spinal fixation, and neuromodulation and repair techniques for spinal cord injuries have reached international advanced levels. Differentiated Advantages: Relying on the powerful trauma platform of the Sixth Affiliated Hospital, it is one of the few centers in China that simultaneously possesses the capabilities for emergency treatment of severe multiple injuries combined with spinal cord injuries, complex open spinal orthopedics, a full range of minimally invasive spinal endoscopic procedures, and comprehensive neuromodulation and rehabilitation of spinal cord injuries. Unlike general spinal specialties, it has outstanding advantages in the comprehensive multidisciplinary treatment of upper cervical spine injuries, post-traumatic spinal cord function reconstruction, and refractory spinal infections/tumors. The spinal surgery ward at the Lingang campus will officially begin operation in June 2026, forming a dual-campus structure of "Xuhui-Lingang".

It is a core subspecialty of the National Orthopedic Medical Center and a national key clinical specialty (joint surgery); a national health commission digital orthopedic innovation demonstration center; a Shanghai clinical medical center for trauma orthopedics and osteoarticular diseases; a doctoral program and postdoctoral research station in orthopedics; a Ministry of Industry and Information Technology orthopedic surgical robot application center; and a national research base for standardized diagnosis and treatment of artificial joint infections. It is affiliated with the National Orthopedic Medical Center, the Shanghai Institute of Limb Microsurgery, and the Shanghai Jiao Tong University Institute of Traumatic Orthopedics. The Joint Surgery Robot Clinical Application Training Center is a core functional unit under the framework of the National Orthopedic Medical Center. Since 2012, it has published over 190 SCI papers, with a highest impact factor of 32.086, led the development of one professional guideline, and achieved patent commercialization value of over 4.5 million yuan.

1. Historical Origins and Spiritual Inheritance

The Department of Orthopedics at the Sixth Affiliated Hospital originated from the hospital's founding in 1904. In 1963, it performed the world's first successful limb replantation, establishing its international standing in orthopedics. Joint Surgery, as a core subspecialty of orthopedics, has developed over decades, inheriting the pioneering spirit of Academician Chen Zhongwei in limb replantation and the innovative genes of Professor Yu Zhongjia's "Chinese Hands." It focuses on adult hip, knee, shoulder, elbow, and ankle joint reconstruction. Adhering to the principles of precise reconstruction, minimally invasive function preservation, comprehensive infection control, and accelerated rehabilitation, it upholds a tiered treatment approach: prioritizing joint preservation, implementing individualized joint replacement in the final stages, and establishing a complete diagnostic and treatment system from early joint preservation to complex revision surgery. After the National Orthopedic Medical Center was established at the Sixth Affiliated Hospital in 2022, joint surgery, as a core sub-discipline, with Professor Zhang Xianlong as the discipline leader, has established "precision, minimally invasive, and intelligent" as the main line of technological evolution.

1. Core Business Operation Efficiency

The hospital has two campuses, Xuhui and Lingang, with 117 approved beds and 145 open beds. It has 23 specialist physicians, including 4 doctoral supervisors and 7 master's supervisors. The hospital performs over 8,200 surgeries annually, consistently ranking first in Shanghai and among the top in China for total hip and knee replacements. It has established a five-zero accelerated rehabilitation system (painless, bloodless, thrombus-free, inflammation-free, and tube-free). The hospital is equipped with orthopedic surgical robots, computer-guided systems, and a 3D-printed PSI personalized guide plate system. It accepts referrals from across the country for complex joint replacements, periprosthetic infections, and joint revision surgeries. It spearheaded the development of the "Guidelines for the Diagnosis and Treatment of Artificial Joint Infections in China" and has conducted multiple national multicenter clinical trials in joint surgery.

1. Discipline Positioning and National/Global Benchmarking

It is a top-tier discipline in joint reconstruction in China, ranking second nationwide (A+++ level) in the Fudan University Orthopedics Specialty Ranking. In March 2023, it was designated by the National Health Commission as one of the three national "Digital Orthopedics Innovation Demonstration Centers". Benchmarking against top joint centers in Europe and America, its robotic-assisted joint replacement, standardized diagnosis and treatment of periprosthetic joint infection (PJI), complex high dislocation DDH hip replacement, and knee/hip preservation tiered treatment have reached international advanced levels. Differentiated Advantages: One of the few centers in China that simultaneously possesses a complete chain of joint-preserving minimally invasive orthopedics, primary complex joint replacement, robotic precision replacement, and revision reconstruction for prosthesis infections; unlike general joint departments, its core advantages lie in addressing global clinical challenges such as artificial joint infections and revision of severely deformed joints. Ranked 2nd nationally in the Fudan University Orthopedics Specialty Ranking (A+++ level).

It is a core subspecialty of the National Orthopedic Medical Center, the Shanghai Institute of Limb Microsurgery, and a National Key Clinical Specialty (Sports Medicine); the Sports Translational Medicine Center of Shanghai Jiao Tong University; the Biomechanics Laboratory of Sports Medicine; a national-level training base for arthroscopy; a doctoral program and postdoctoral research station in orthopedics; a unit undertaking the National Key Research and Development Program on Biomedical Materials; and a national-level research base for the transformation of biomaterials and devices for sports injuries. It has undertaken one key research and development project of the Ministry of Science and Technology (development of induced regenerative artificial ligaments) and four National Natural Science Foundation of China projects, with research funding exceeding 25 million yuan. The company has applied for 68 national/international patents, completed the commercialization of 36 patents, and obtained 7 registration certificates. It has developed products with independent intellectual property rights, including sports medicine surgical robots, knee ligament reconstruction systems, and permanent balloon support systems for the shoulder joint. The company has also led the development of 2 domestic guidelines and 1 expert consensus.

1. Historical Origins and Spiritual Inheritance

The Department of Sports Medicine at the Sixth People's Hospital was originally the Arthroscope Surgery Department, which started in 1990, relying on the hospital's profound expertise in limb replantation. After 2000, it became a specialized sports medicine center under the leadership of Professor Zhao Jinzhong, developing independently and becoming the largest sports medicine clinical treatment center in China in terms of bed capacity and surgical volume. In 2014, it was approved as a National Key Clinical Specialty. Inheriting the spirit of minimally invasive surgery to preserve function, anatomical reconstruction, precise biomechanical repair, and translational medical research, the department adheres to a tiered treatment approach: prioritizing conservative rehabilitation, followed by necessary arthroscopic minimally invasive procedures, individualized reconstruction for complex cases, and considering both professional athletes and the general population with sports injuries.

1. Core Business Operation Efficiency

The two campuses in Xuhui and Lingang have a combined total of over 200 beds; the medical team consists of 35 people, including 19 with senior professional titles, 3 doctoral supervisors, and 7 master's supervisors; the annual number of arthroscopic surgeries is 15,000, accounting for more than 60% of the total number of sports medicine surgeries in Shanghai, ranking among the top in the country. Equipped with a high-definition 4K arthroscopy system, intraoperative navigation, and a sports biomechanical testing platform; accepting referrals from across the country for complex cases such as massive rotator cuff injuries, recurrent shoulder dislocations, and multiple ligament injuries of the knee joint; having held 46 national-level arthroscopy training courses, training tens of thousands of orthopedic surgeons nationwide; leading multiple national-level research projects, developing over 30 original surgical procedures, and having several surgical techniques included in the internationally authoritative orthopedic textbook "Campbell's Orthopedic Surgery," achieving the industrialization of implant patents.

1. Discipline Positioning and National/Global Benchmarking

A top-tier sports medicine discipline in China, Fudan University's orthopedics department ranks among the best in the country. As a core sub-discipline of the National Orthopedic Medical Center, the department holds an internationally leading position in shoulder and knee joint functional reconstruction. Professor Zhao Jinzhong's minimally invasive knee joint release technique was included in the global orthopedic "bible," *Cambell's Complete Guide to Orthopedic Surgery*, making it the only original technique by a Chinese doctor to be included. The "sandwich reconstruction" of the posterior cruciate ligament (PCL) has been hailed by international peers as a milestone in PCL reconstruction history. Benchmarking against top sports medicine centers in Europe and America, the department's advanced techniques in multiple knee ligament reconstruction, complex shoulder instability triple-insurance reconstruction, repair of massive irreparable rotator cuff tears, and minimally invasive knee joint ankylosis release have reached international advanced levels. Differentiated Advantages: One of the few centers in China that simultaneously possesses a complete chain of research and development and commercialization of biomaterials for sports injuries, including minimally invasive total arthroscopy of the shoulder, knee, hip, and ankle; unlike general sports medicine departments, its core advantages are concentrated on recurrent, bone defect-type shoulder dislocations, and complex knee injuries with multiple ligaments, among other globally challenging sports injuries.

The Department of Bone Oncology (Comprehensive Diagnosis and Treatment Center for Bone and Soft Tissue Tumors, COC) at the Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine was established in 2008, branching off from the Department of Orthopedics. It is a core subspecialty of the National Orthopedic Medical Center. The department's traditional strength lies in limb-sparing treatment of malignant bone tumors of the extremities, with its signature techniques being precise resection and functional reconstruction of tumors of the spine, pelvis, and sacrum. It is characterized by multidisciplinary team (MDT) treatment and comprehensive one-stop service throughout the entire disease course, positioning itself as one of the centers with the highest number of bone and soft tissue tumor patients treated in East China and even nationwide. The department is a pilot construction unit for comprehensive oncology treatment centers in Shanghai municipal hospitals and received the Excellence Award from the Shanghai Outpatient Management Quality Control Center in 2021.

Historical Origins and Spiritual Inheritance:

Established in 2008, the Department of Bone Oncology is an important component of the Department of Orthopedics at the Sixth People's Hospital. Founded by Academician Chen Zhongwei, a pioneer in finger replantation, the department performed the world's first finger replantation surgery in 1963. Academician Chen also pioneered limb-sparing surgery in bone tumors, performing limb-sparing surgery and implanting tumor-type prostheses for osteosarcoma patients as early as 2002, establishing a tradition of "limb preservation first." The department's first director, Professor Dong Yang, has nearly forty years of experience in trauma orthopedics, bone oncology, and bone diseases. He has participated in academic exchanges in Switzerland, France, Germany, the United States, the United Kingdom, and other countries, laying the foundation for a clinical culture of "never giving up and focusing on patient needs."

Core business operational efficiency:

The department currently has 48 beds, 7 senior physicians, and performs over 2,000 surgeries annually. Its five-year survival rate for osteosarcoma is among the leading levels in China and advanced levels internationally. Its high-dose chemotherapy and comprehensive limb-sparing treatment for osteosarcoma and soft tissue sarcoma are nationally leading. The department hosts two national continuing education programs annually: the "Shanghai Advanced Symposium on Limb-Sparing Treatment of Osteosarcoma" and "Multidisciplinary Diagnosis and Treatment of Bone Tumors and Diseases Based on Clinical Cases." It has trained 34 doctoral, master's, and postdoctoral students, and has 2 doctoral supervisors and 3 master's supervisors.

Discipline Positioning and Benchmarking:

It is a core subspecialty of the National Orthopedic Medical Center (approved in 2022) and a pilot construction unit of the Shanghai Municipal Hospital Bone and Soft Tissue Tumor Comprehensive Diagnosis and Treatment Center (COC) (established in 2022). The department undertakes the construction task of the bone tumor direction of the Shanghai Municipal Key Clinical Medical Center. In terms of scientific research, it has undertaken 10 National Natural Science Foundation of China projects and 16 provincial and ministerial projects, published more than 240 SCI papers with a total impact factor of over 750, held more than 20 utility model patents, 2 of which have been successfully commercialized, led or participated in 6 expert consensus and guidelines, and edited 4 monographs.

The Department of Otolaryngology-Head and Neck Surgery at Shanghai Sixth People's Hospital, founded in 1904, is a national key clinical specialty and a key discipline of Shanghai Municipality. Relying on the Shanghai Key Laboratory of Sleep-Disordered Breathing and the Otolaryngology Research Institute of Shanghai Jiao Tong University, it is a first-class otolaryngology-head and neck surgery center integrating medical treatment, scientific research, and teaching. The department is divided into three sub-disciplines: otology, rhinology, and otolaryngology-head and neck surgery. It also houses the Shanghai Hearing Testing Center, the Snoring Treatment Center, and the Shanghai Jiao Tong University Vertigo Treatment Center. It ranks 7th nationally in the Fudan University "Best Specialty Reputation Ranking" and consistently ranks 2nd to 3rd among specialties in East China.

Historical Origins and Spiritual Inheritance:

Established in 1904, the department is one of the oldest otolaryngology specialties in China. It established the Inner Ear Electrophysiology Research Laboratory in 1985, the Shanghai Hearing Testing Center in 1989, the Snoring Treatment Center in 2002, spearheaded the establishment of the Shanghai Jiao Tong University Otolaryngology Research Institute in 2005, the Shanghai Jiao Tong University Vertigo Treatment Center in 2009, and the Shanghai Oriental Otolaryngology Research Institute in 2010. In 2011, it was selected as a National Key Clinical Specialty by the Ministry of Health, and in 2013, it was selected as a key discipline of Shanghai Municipality. In 2018, it was approved to establish the Shanghai Key Laboratory for Sleep-Disordered Breathing. The department has developed significant clinical advantages in areas such as ear microsurgery, ear neurosurgery, lateral skull base surgery, nasal skull base surgery, and snoring surgery.

Core business operational efficiency:

The department currently has 36 physicians, over 65% of whom hold a doctoral degree in medicine, including 8 chief physicians, 9 associate chief physicians, 5 doctoral supervisors, and 7 master's supervisors. The department performs over 3600 surgeries annually. In acoustic neuroma resection, the department has completed over 500 cases, achieving a 98% complete tumor resection rate and a 96.8% anatomical preservation rate of the facial nerve, with treatment results comparable to internationally renowned skull base surgery centers. Facial nerve decompression, transplantation, and anastomosis surgery for peripheral facial paralysis has been completed in over 300 cases, with a long-term overall effective rate exceeding 85%. Lateral skull base tumor surgery (glomus venosus tumor, meningioma, teratoma, petrous apex cholesteatoma, etc.) has been completed in over 300 cases, achieving satisfactory results.

Discipline Positioning and Benchmarking:

It is a National Key Clinical Specialty (2011), a Shanghai Municipal Key Discipline (2013), and a Shanghai Key Laboratory for Sleep-Disordered Breathing (2018). Professor Yin Shankai serves as the President of Shanghai Sixth People's Hospital, Director of the Institute of Otolaryngology at Shanghai Jiao Tong University, and Director of the Shanghai Key Laboratory for Sleep-Disordered Breathing. He previously served as Vice Chairman of the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association and Chairman of the Otolaryngology-Head and Neck Surgery Branch of the Shanghai Medical Association. He has received honors such as the National Science Fund for Distinguished Young Scholars and the title of "Outstanding Young and Middle-aged Expert with Outstanding Contributions" from the Ministry of Human Resources and Social Security. Professor Shi Haibo serves as the department director, a standing committee member of the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, and the incoming chairman of the Otolaryngology-Head and Neck Surgery Specialty Branch of the Shanghai Medical Association. He has received titles such as "National Renowned Doctor with Outstanding Demeanor," "Good Doctor of Shanghai," and "Shanghai Medical Craftsman." The department ranked 7th nationwide in Fudan University's "Best Specialty Reputation Ranking" in 2019, 10th nationwide in Peking University's "Best Clinical Disciplines in China" ranking, and 8th nationwide in the Chinese Academy of Medical Sciences' "Hospital Scientific and Technological Influence Ranking for Specialty Scientific and Technological Influence."